Carla Goerish, MD
Obstetrics & Gynecology · Mankato, MNNPI 1871571893
Payments from drug & device makers
Across 39 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$70
- Monaghan Medical Corporation$69
- Exeltis, USA Inc.$67
- Hologic Sales And Service, LLC$66
- Avanos Medical$59
- Exact Sciences$51
- plus $362 from 16 others
What the payments were for
- Food & beverage$744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 5 | $70 |
| Monaghan Medical Corporation | 1 | $69 |
| Exeltis, USA Inc. | 4 | $67 |
| Hologic Sales And Service, LLC | 4 | $66 |
| Avanos Medical | 2 | $59 |
| Exact Sciences | 3 | $51 |
| Northgate Technologies, Inc. | 1 | $51 |
| Bayer | 3 | $48 |
| Applied Medical Resources Corporation | 1 | $35 |
| Davol Inc. | 2 | $32 |
| Johnson & Johnson | 1 | $32 |
| Roche Diagnostics Corporation | 2 | $29 |
| Olympus America Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Medtronic | 1 | $15 |
| Coopersurgical, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
| Merck | 1 | $12 |
| Astellas Pharma US Inc | 1 | $12 |
| Myovant Sciences Inc. | 1 | $11 |
| Therapeuticsmd, Inc. | 1 | $11 |
| AstraZeneca | 1 | $11 |
How this compares
$744 in reported general payments places this provider in the 75th percentile of 615 obstetrics & gynecology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $2,110 |
| Estradiol (Once Weekly)Estradiol | 15 | $1,226 |
| ProgesteroneProgesterone, Micronized | 14 | $586 |
| ValacyclovirValacyclovir Hcl | 18 | $568 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mankato
- Amy EastensonSt Louis Park$6M
- Christy Boraas AlslebenMinneapolis$4.3M
- Eric EnglishLake Elmo$228K
- Courtney KerestesMinneapolis$209K
- Petra CaseyRochester$156K
- Matthew PalmerCrystal$138K
- Eugen CampianRed Wing$137K
- Kirk ShibleyEdina$130K
- Tatnai BurnettRochester$91K
- Kelly MorrisonMinneapolis$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.